154 related articles for article (PubMed ID: 19250063)
41. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
Cui W; Zhang S; Shan C; Zhou L; Zhou Z
FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
[TBL] [Abstract][Full Text] [Related]
42. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
43. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
[TBL] [Abstract][Full Text] [Related]
44. The canine HMGA1.
Murua Escobar H; Soller JT; Richter A; Meyer B; Winkler S; Flohr AM; Nolte I; Bullerdiek J
Gene; 2004 Apr; 330():93-9. PubMed ID: 15087128
[TBL] [Abstract][Full Text] [Related]
45. HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
De Martino M; Esposito F; Pellecchia S; Cortez Cardoso Penha R; Botti G; Fusco A; Chieffi P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344629
[TBL] [Abstract][Full Text] [Related]
46. miR-145 inhibits breast cancer cell growth through RTKN.
Wang S; Bian C; Yang Z; Bo Y; Li J; Zeng L; Zhou H; Zhao RC
Int J Oncol; 2009 May; 34(5):1461-6. PubMed ID: 19360360
[TBL] [Abstract][Full Text] [Related]
47. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
Sun Z; Li S; Kaufmann AM; Albers AE
Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
[TBL] [Abstract][Full Text] [Related]
48. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.
Zhang Q; Wang Y
J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M
Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617
[TBL] [Abstract][Full Text] [Related]
50. Tissues tell the real tale of breast cancer.
Cottingham K
J Proteome Res; 2007 Jun; 6(6):2052. PubMed ID: 17577952
[No Abstract] [Full Text] [Related]
51. Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.
Jia XP; Meng LL; Fang JC; Wang HW; Chen J; Zhou J; Wang CN; Jiang WF
Clin Lab; 2018 Jun; 64(6):915-921. PubMed ID: 29945308
[TBL] [Abstract][Full Text] [Related]
52. High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells.
Xi Y; Li YS; Tang HB
Mol Cell Biochem; 2013 Feb; 374(1-2):173-80. PubMed ID: 23229232
[TBL] [Abstract][Full Text] [Related]
53. CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1.
Li KK; Qi Y; Xia T; Yao Y; Zhou L; Lau KM; Ng HK
PLoS One; 2015; 10(5):e0127910. PubMed ID: 26009886
[TBL] [Abstract][Full Text] [Related]
54. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
55. Role of High-mobility Group Protein A Isoforms and Their Clinicopathologic Significance in Primary Retinoblastoma.
Singh MK; Singh L; Sen S; Pushker N; Sharma A; Ahamad FC; Chawla B; Kashyap S
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):244-250. PubMed ID: 26657872
[TBL] [Abstract][Full Text] [Related]
56. Molecular mechanism of HMGA1 deregulation in human neuroblastoma.
Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Gulino A
Cancer Lett; 2005 Oct; 228(1-2):97-104. PubMed ID: 15923078
[TBL] [Abstract][Full Text] [Related]
57. HMGA molecules in neuroblastic tumors.
Cerignoli F; Ambrosi C; Mellone M; Assimi I; di Marcotullio L; Gulino A; Giannini G
Ann N Y Acad Sci; 2004 Dec; 1028():122-32. PubMed ID: 15650238
[TBL] [Abstract][Full Text] [Related]
58. Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.
Yuan S; Pan Q; Fu C; Bi Z
Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
[TBL] [Abstract][Full Text] [Related]
59. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
Huso TH; Resar LM
Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
[TBL] [Abstract][Full Text] [Related]
60. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells.
Qin W; Shi Y; Zhao B; Yao C; Jin L; Ma J; Jin Y
PLoS One; 2010 Feb; 5(2):e9429. PubMed ID: 20195546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
